CID 86574714

5'-cgcgttacga-3'

Structural Information

Molecular Formula
C97H124N38O61P10
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OC3CC(OC3COP(=O)(O)OC4CC(OC4COP(=O)(O)OC5CC(OC5COP(=O)(O)OC6CC(OC6COP(=O)(O)OC7CC(OC7COP(=O)(O)O)N8C=CC(=NC8=O)N)N9C=NC1=C9N=C(NC1=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)O
InChI
InChI=1S/C97H124N38O61P10/c1-38-19-129(96(145)124-85(38)137)67-13-44(55(183-67)26-173-206(166,167)196-49-18-72(135-37-114-77-84(135)120-92(105)123-89(77)141)187-59(49)30-177-201(156,157)190-43-12-66(128-8-5-62(100)117-95(128)144)181-53(43)24-171-205(164,165)195-48-17-71(134-36-113-76-83(134)119-91(104)122-88(76)140)186-58(48)29-175-199(152,153)188-41-10-64(126-6-3-60(98)115-93(126)142)179-51(41)22-168-197(147,148)149)191-202(158,159)172-25-54-45(14-68(182-54)130-20-39(2)86(138)125-97(130)146)192-203(160,161)174-27-56-46(15-69(184-56)132-34-111-74-79(102)107-32-109-81(74)132)194-204(162,163)170-23-52-42(11-65(180-52)127-7-4-61(99)116-94(127)143)189-200(154,155)176-28-57-47(16-70(185-57)133-35-112-75-82(133)118-90(103)121-87(75)139)193-198(150,151)169-21-50-40(136)9-63(178-50)131-33-110-73-78(101)106-31-108-80(73)131/h3-8,19-20,31-37,40-59,63-72,136H,9-18,21-30H2,1-2H3,(H,150,151)(H,152,153)(H,154,155)(H,156,157)(H,158,159)(H,160,161)(H,162,163)(H,164,165)(H,166,167)(H2,98,115,142)(H2,99,116,143)(H2,100,117,144)(H2,101,106,108)(H2,102,107,109)(H,124,137,145)(H,125,138,146)(H2,147,148,149)(H3,103,118,121,139)(H3,104,119,122,140)(H3,105,120,123,141)
InChIKey
FQOHAUNTLFZDHM-UHFFFAOYSA-N
Compound name
[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[2-[[[2-[[[2-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[2-[[[5-(2-amino-6-oxo-1H-purin-9-yl)-2-[[[5-(4-amino-2-oxopyrimidin-1-yl)-2-(phosphonooxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxymethyl]oxolan-3-yl] [5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl hydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

3106.5146 Da
Monoisotopic Mass

-21.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 3107.5219 285.2
[M+Na]+ 3129.5038 288.8
[M-H]- 3105.5073 286.0
[M+NH4]+ 3124.5484 286.5
[M+K]+ 3145.4778 286.9
[M+H-H2O]+ 3089.5119 284.8
[M+HCOO]- 3151.5128 286.9
[M+CH3COO]- 3165.5285 287.4
[M+Na-2H]- 3127.4893 292.3
[M]+ 3106.5141 286.7
[M]- 3106.5151 286.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.